{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:55:08Z","timestamp":1767135308353,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":55,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd005309.pub2","type":"reference-entry","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T07:54:39Z","timestamp":1128671679000},"source":"Crossref","is-referenced-by-count":0,"title":["Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children"],"prefix":"10.1002","author":[{"given":"TJ","family":"Lasserson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CJ","family":"Cates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A-B","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EH","family":"Steele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,10,19]]},"reference":[{"issue":"Suppl 45","key":"10.1002\/14651858.CD005309.pub2-BIB1|cit1","first-page":"Abstract No: P1","article-title":"Relative potency of beclomethasone propionate (BDP), delivered by HFA-MDI, and fluticasone propionate (FP) delivered by diskus [Abstract]","volume":"22","author":"Ahrens","year":"2003","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD005309.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1053\/rmed.2000.1025","article-title":"Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma","volume":"95","author":"Aubier","year":"2001","journal-title":"Respiratory Medicine"},{"issue":"Suppl 33","key":"10.1002\/14651858.CD005309.pub2-BIB3|cit3","first-page":"49S","article-title":"Cost-effectiveness of fluticasone compared with beclomethasone extrafine aerosol","volume":"18","author":"O'Reilly","year":"2001","journal-title":"European Respiratory Journal"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005309.pub2-BIB4|cit4","first-page":"A186","article-title":"Equivalence study of 800 mcg\/day HFA-BDP extrafine aerosol and 1000 mcg\/day HFA-fluticasone propionate","volume":"161","author":"Wettengel","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005309.pub2-BIB5|cit5","first-page":"Abstract No: 76","article-title":"Airway systemic ratio of hydrofluoroalkane fluticasone and beclomethasone in asthmatics [Abstract]","volume":"109","author":"Currie","year":"2002","journal-title":"Journal of Allergy, Asthma and Immunolgy"},{"issue":"10","key":"10.1002\/14651858.CD005309.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/thorax.57.10.865","article-title":"Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma","volume":"57","author":"Currie","year":"2002","journal-title":"Thorax"},{"issue":"5","key":"10.1002\/14651858.CD005309.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1081-1206(10)62907-9","article-title":"A randomized, double-blind comparison of beclasmethasone dipropionate extrafine aerosol and fluticasone propionate","volume":"86","author":"Fairfax","year":"2001","journal-title":"Annals of Allergy, Asthma and Immunology"},{"issue":"Suppl 45","key":"10.1002\/14651858.CD005309.pub2-BIB8|cit8","first-page":"Abstract No: P2","article-title":"Acceptability and efficacy of beclomethasone dipropionate (B\u00e9clojet HFA\u00ae) and fluticasone dipropionate (Flixotide HFA\u00ae, FDP) associated with the Volumatic\u00ae spacer in adults with mild to moerate persistent asthma","volume":"22","author":"Huchon","year":"2003","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD005309.pub2-BIB9|cit9","series-title":"American Thoracic Society 100th International Conference, May 21-26","first-page":"A37, Poster J12","article-title":"Improvement of asthma control: comparative study with beclomethasone extra fine aerosol, fluticasone or budesonide [Abstract]","author":"Giraud","year":"2004"},{"issue":"6","key":"10.1002\/14651858.CD005309.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.rmed.2004.10.024","article-title":"Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide","volume":"99","author":"Molimard","year":"2005","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD005309.pub2-BIB11|cit11","series-title":"Allergy","first-page":"177","article-title":"A double-blind comparison of fluticasone (FP) and beclomethasone extra-fine aerosol (HFA-BDP) in children with symptomatic mild to moderate asthma","author":"Price","year":"2003"},{"issue":"Suppl 45","key":"10.1002\/14651858.CD005309.pub2-BIB12|cit12","first-page":"3344","article-title":"Dose comparability of fluticasone (F) and beclomethasone extrafine aerosol (Q) in children with symptomatic asthma using dose step down study design [Abstract]","volume":"22","author":"Price","year":"2003","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD005309.pub2-BIB13|cit13","series-title":"World Allergy Organisation Congress, Vancouver, Canada, 7-12 September","first-page":"P","article-title":"Asthma quality of life and systemic safety of beclomethasone extrafine aerosol (Q) and fluticasone in children","author":"Aalderen","year":"2003"},{"issue":"5","key":"10.1002\/14651858.CD005309.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1472-8206.2003.00191.x","article-title":"Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma","volume":"17","author":"Dubus","year":"2003","journal-title":"Fundamental & Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD005309.pub2-BIB15|cit15","first-page":"45","article-title":"Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study","volume":"7","year":"2003","journal-title":"European Review for Medical & Pharmacological Sciences"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005309.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF02500683","article-title":"Effects on bone mineral density of inhaled corticosteroids (fluticasone propionate and beclomethasone dipropionate: a two year double-blind randomised study [Abstract]","volume":"6","author":"Adams","year":"1996","journal-title":"Osteoporosis International"},{"issue":"Suppl 23","key":"10.1002\/14651858.CD005309.pub2-BIB17|cit17","first-page":"52s","article-title":"A two-year double-blind randomised study comparing the effects of fluticasone propionate 1000 mcg\/day and beclomethasone dipropionate 2000 mcg\/day on bone mineral density and bone metabolism in asthma patients","volume":"9","author":"Egan","year":"1996","journal-title":"European Respiratory Journal"},{"issue":"6","key":"10.1002\/14651858.CD005309.pub2-BIB18|cit18","first-page":"1267","article-title":"A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years","volume":"13","author":"Egan","year":"1999","journal-title":"European Respiratory Journal"},{"issue":"7","key":"10.1002\/14651858.CD005309.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/thorax.58.7.632","article-title":"Rapid effect of inhaled steroids on nocturnal worsening of asthma","volume":"58","author":"Frezza","year":"2003","journal-title":"Thorax"},{"issue":"Suppl 17","key":"10.1002\/14651858.CD005309.pub2-BIB20|cit20","first-page":"257s","article-title":"Inhaled steroids in the long-term treatment of asthma: a double-blind, randomised, parallel group comparison of fluticasone propionate 500 \u00b5g daily and beclomethasone dipropionate 1000 \u00b5g daily over 12 months [Abstract]","volume":"6","author":"Kesten","year":"1993","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD005309.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0954-6111(05)80264-1","article-title":"Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler","volume":"87","author":"Lundback","year":"1993","journal-title":"Respiratory Medicine"},{"issue":"10","key":"10.1002\/14651858.CD005309.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/rccm.2105013","article-title":"Systemic effect comparisons of six inhaled corticosteroid preparations","volume":"165","author":"Martin","year":"2002","journal-title":"American Journal of Respiratory & Critical Care Medicine"},{"key":"10.1002\/14651858.CD005309.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/thorax.55.5.375","article-title":"Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects","volume":"55","author":"Medici","year":"2000","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD005309.pub2-BIB24|cit24","first-page":"A407","article-title":"One-year treatment with inhaled fluticasone propionate or beclomethasone dipropionate does not affect bone density and bone metabolism. A randomised, parallel group study in adult asthmatics","volume":"157","author":"Medici","year":"1998","journal-title":"American Journal of Respiratory & Critical Care Medicine"},{"key":"10.1002\/14651858.CD005309.pub2-BIB25|cit25","series-title":"European Respiratory Society; Oct 9-13; Madrid, Spain","first-page":"P3110","article-title":"Effect of long term inhaled fluticasone propionate (FP) 250mcg bd and beclomethasone dipropionate (BDP) 500 BCG BD of marker of bone turn over in asthmatic adult patients","author":"Migliori","year":"1999"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005309.pub2-BIB26|cit26","first-page":"A407","article-title":"Fluticasone propionate (FP) is more effective than higher doses of beclomethasone dipropionate (BDP) in patients with moderate asthma [Abstract]","volume":"157","author":"Murray","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005309.pub2-BIB27|cit27","first-page":"A185","article-title":"Cost of changing treatment with CFC-BDP ro HFA-BDP extrafine aersosol 'QVAR' in a \"Real Life\" clinical trial design over 1 year","volume":"161","author":"Price","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD005309.pub2-BIB28|cit28","series-title":"European Respiratory Society; Oct 9-13; Madrid, Spain","first-page":"P3113","article-title":"Asthma patient treatment goals and lung function - fluticasone propionate and beclomethasone dipropionate compared in a \"real-life\" trial design","author":"Price","year":"1999"},{"issue":"2","key":"10.1002\/14651858.CD005309.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/0894268041457174","article-title":"Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers","volume":"17","author":"Welch","year":"2004","journal-title":"Journal of Aerosol Medicine"},{"issue":"5","key":"10.1002\/14651858.CD005309.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/adc.76.5.405","article-title":"Adrenal function and high dose inhaled corticosteroids for asthma","volume":"76","author":"Yiallouros","year":"1997","journal-title":"Archives of Disease in Childhood"},{"issue":"4","key":"10.1002\/14651858.CD005309.pub2-BIB31|cit31","first-page":"186","article-title":"Comparison of the clinical effect of fluticasone propionate and beclomethasone dipropionate in patients with bronchial asthma","volume":"78","author":"Chlumsky","year":"1998","journal-title":"Prakticky Lekar"},{"issue":"5","key":"10.1002\/14651858.CD005309.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s001980050085","article-title":"Effect of inhaled corticosteroids on bone mineral density in childhood asthma: comparison of fluticasone propionate with beclomethasone dipropionate","volume":"8","author":"Gregson","year":"1998","journal-title":"Osteoporosis International"},{"issue":"4","key":"10.1002\/14651858.CD005309.pub2-BIB33|cit33","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003274","article-title":"Budesonide for chronic asthma in children and adults (Cochrane review)","author":"Adams","year":"1999","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005309.pub2-BIB34|cit34","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002738","article-title":"Inhaled beclomethasone at different doses for chronic asthma (Cochrane review)","author":"Adams","year":"1999","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005309.pub2-BIB35|cit35","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003534.pub2","article-title":"Inhaled fluticasone at different doses for chronic asthma (Cochrane review)","author":"Adams","year":"2005","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005309.pub2-BIB36|cit36","article-title":"Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children (Cochrane review)","author":"Adams","year":"2005","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005309.pub2-BIB37|cit37","article-title":"Inhaled fluticasone versus placebo for chronic asthma in adults and children (Cochrane review)","author":"Adams","year":"2005","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005309.pub2-BIB38|cit38","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003135.pub2","article-title":"Inhaled beclomethasone versus placebo for chronic asthma (Cochrane review)","author":"Adams","year":"2005","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"Suppl B","key":"10.1002\/14651858.CD005309.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0954-6111(00)90153-7","article-title":"Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group","volume":"94","author":"Ayres","year":"2000","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD005309.pub2-BIB40|cit40","unstructured":"British National Formulary http:\/\/www.bnf.org"},{"issue":"1","key":"10.1002\/14651858.CD005309.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.rmed.2004.05.015","article-title":"True device compliance: the need to consider both competence and contrivance","volume":"99","author":"Brennan","year":"2005","journal-title":"Respiratory Medicine"},{"issue":"7318","key":"10.1002\/14651858.CD005309.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/bmj.323.7318.896","article-title":"Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma","volume":"323","author":"Brocklebank","year":"2001","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005309.pub2-BIB43|cit43","first-page":"i1","article-title":"British Guideline on the Management of Asthma","volume":"58","year":"2003","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD005309.pub2-BIB44|cit44","unstructured":"Cates CJ 2003"},{"key":"10.1002\/14651858.CD005309.pub2-BIB45|cit45","first-page":"Available at: h","article-title":"Global Strategy for Asthma Management and Prevention","volume-title":"NIH Publication 02-3659","author":"Global","year":"2002"},{"issue":"2","key":"10.1002\/14651858.CD005309.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1378\/chest.115.2.343","article-title":"Hydrofluoroalkane-134a beclomethasone dipropionate, 400 mug, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 mug, for the treatment of moderate asthma","volume":"115","author":"Gross","year":"1999","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD005309.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"6","key":"10.1002\/14651858.CD005309.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1183\/09031936.98.12061346","article-title":"Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone","volume":"12","author":"Leach","year":"1998","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD005309.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1081-1206(10)61410-X","article-title":"Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults","volume":"93","author":"Melani","year":"2004","journal-title":"Annals of Allergy Asthma & Immunology"},{"issue":"6","key":"10.1002\/14651858.CD005309.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1378\/chest.122.6.1956","article-title":"Efficacy and safety of beclomethasone dipropionate extarfine aerosol in chilhood asthma a 12 week randomized double blind placebo controlled study","volume":"122","author":"Nayak","year":"2002","journal-title":"Chest"},{"key":"10.1002\/14651858.CD005309.pub2-BIB51|cit51","unstructured":"National Heart, Lung, Blood Institute National Asthma Education and Prevention Program Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma http:\/\/www.nhlbi.nih.gov\/guidelines\/asthma\/asthgdln.htm"},{"issue":"4","key":"10.1002\/14651858.CD005309.pub2-BIB52|cit52","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004109.pub2","article-title":"High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children (Cochrane review)","author":"Powell","year":"2003","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005309.pub2-BIB53|cit53","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001282","article-title":"Beclomethasone for asthma in children: effects on linear growth (Cochrane review)","author":"Sharek","year":"1999","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD005309.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1368-5031.2004.00273.x","article-title":"The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 1): an update of clinical experience in adults","volume":"58","author":"Schayck","year":"2004","journal-title":"Interntaional Journal of Clinical Practice"},{"issue":"8","key":"10.1002\/14651858.CD005309.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1368-5031.2004.00274.x","article-title":"The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (Part 2): Clinical experience in children","volume":"58","author":"Schayck","year":"2004","journal-title":"International Journal of Clinical Practice"}],"updated-by":[{"DOI":"10.1002\/14651858.cd005309.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T00:00:00Z","timestamp":1145404800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005309.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:47:47Z","timestamp":1628531267000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005309.pub2"}},"subtitle":[],"editor":[{"given":"Toby","family":"Lasserson","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,10,19]]},"references-count":55,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005309.pub2","relation":{},"subject":[],"published":{"date-parts":[[2005,10,19]]}}}